- Completed final formulation for Skinuva® Scar.
Achievements
Skinuva Achievements Timeline
-
Skinuva® Scar
-
Skinuva® Brite
December 2016
January 2017
- Initiated Study Arm 1—Safety and Efficacy of Skinuva® Scar Cream.
- Patent Pending.
February 2017
- Dermatologic Tested.
March 2017
- Trademark granted for Skinuva®
April 2017
- Study Arm 1 concluded and showed incredibly positive results.
May 2017
- Passed compliance for various tests for establish safety and stability of Skinuva® Scar.
- Initiated Study Arm 2—Double Blinded, Randomized Multicenter Study to evaluate Skinuva®Scar vs Silicone Cream.
September 2017
- Study Arm 2 ended enrollment.
- Initiated Study Arm 1-Safety and Efficacy of Skinuva® Stretch Mark Cream.
November 2017
- Initiated Study Arm 1-Safety and Efficacy of Skinuva® Acne Serum.
December 2017
- Topical Scar Cream Review Article accepted for publication, in press.
- Study Arm 2 was concluded, nearly 50 patients were enrolled.
January 2018
- Production of Skinuva® Scar.
- Submission of Skinuva® Scar clinical data article.
February 2018
- Formal launching of Skinuva® Scar at American Academy of Dermatology, San Diego.
March 2018
- Journal Acceptance of Publication: Topical Agents for Scar Management: Are They Effective?Zoumalan CI. Journal of Drugs in Dermatology.
August 2018
- Journal Publication: Safety and Efficacy of a Scar Cream Consisting of Highly Selective Growth Factors Within a Silicone Cream Matrix: A Double-Blinded, Randomized, Multicenter Study. Zoumalan CI, Tadayon SC, Roostaeian J, Rossi AM, Gabriel A. Aesthetic Surgery Journal. 2018 Jul 31
November 2019
- Skinuva® receives full patent for its next generation scar cream formula.
March 2019
- Completed final formulation for Skinuva® Brite.
May 2019
- Initiated Study Arm 1—Safety and Efficacy of Skinuva® Brite Cream.
June 2019
- Dermatologic Tested.
July 2019
- Study Arm 1 concluded and showed safety and high efficacy profile.
August 2019
- Passed compliance for various tests for establish safety and stability of Skinuva® Brite.
September 2019
- Initiated Study Arm 2—Skinuva® Brite vs. hydroquinone 4%: head to head trial.
November 2019
- Study Arm 2 ended enrollment.
January 2020
- Submission of Journal publication: Skinuva® Brite vs. hydroquinone 4%: head to head trial.
February 2020
- Production of Skinuva® Brite.
March 2020
- Launch of Skinuva® Brite.